Cancer‐associated fibroblasts at the unfavorable desmoplastic stroma promote colorectal cancer aggressiveness: Potential role of <scp>ADAM9</scp>
Tadakazu Ao, Satsuki Mochizuki, Yoshiki Kajiwara, Keisuke Yonemura, Takehiro Shiraishi, K Nagata, Eiji Shinto, Koichi Okamoto, Ines P. Nearchou, Hideyuki Shimazaki, Yoji Kishi, Yasunori Okada, Hideki Ueno
Abstract
Abstract The tumor microenvironment plays a key role in cancer aggressiveness. Desmoplastic reaction (DR), morphologically classified as Mature, Intermediate and Immature types, has previously been shown to be highly prognostic in colorectal cancer (CRC) and it consists to a large extent of cancer‐associated fibroblasts (CAFs). The aim of our study was to characterize the molecular background of DR and understand the effects of CAFs in tumor aggressiveness. The prognostic significance of DR was initially examined in 1497 patients. Then CAFs originating from patient tissues with different DR types were isolated and their impact on tumor growth was examined both in vitro and in vivo. DR was shown to be highly prognostic, with patients within the Immature DR group conferring the worst relapse‐free survival. The conditioned media of CAFs from tumor with Immature‐type DR (CAFs Immature ) significantly increased proliferation and migration of CRC cell lines and growth of CRC‐derived organoids compared to that of CAFs from Mature‐type DR (CAFs Mature ). Subcutaneous or orthotopic implantation of CRC cells together with CAFs Immature in mice significantly promoted tumor growth and dissemination compared to implantation with CAFs Mature . Systematic examination of the expression of “a disintegrin and metalloproteinases” (ADAMs) in CAFs isolated from CRC tissues showed that the secreted isoform of ADAM9 (ADAM9s) was significantly higher in CAFs Immature than in CAFs Mature . Knockdown of ADAM9s in CAFs Immature abrogated the promoting effects on CRC cell proliferation and migration. CAFs‐derived ADAM9s is implicated in deteriorating survival in CRC patients with Immature‐type DR by increasing tumor cell proliferation and dissemination.